We showed here that MSLN reshapes the immune matrix of the tumor microenvironment, recruiting T cells CD8+ and macrophages CD68+, increasing the collagen type I protein, and contributes to the establishment of functional and mechanical anti-tumor barrier in MPM mitigating the risk of death. Here, CD8A is linked to neoplasm.